Cholescintigraphy with 99mTc-hepatobiliary radiopharmaceuticals has been an important, clinically useful diagnostic imaging study for almost 4 decades. It continues to be in much clinical demand; however, the indications, methodology, and interpretative criteria have evolved over the years. This review will emphasize state-of-the-art methodology and diagnostic criteria for various clinical indications, including acute cholecystitis, chronic acalculous gallbladder disease, high-grade and partial biliary obstruction, and the postcholecystectomy pain syndrome, including sphincter-of-Oddi dysfunction and biliary atresia. The review will also emphasize the use of diagnostic pharmacologic interventions, particularly sincalide.
CITATION STYLE
Ziessman, H. A. (2014). Hepatobiliary scintigraphy in 2014. Journal of Nuclear Medicine Technology, 42(4), 249–259. https://doi.org/10.2967/jnumed.113.131490
Mendeley helps you to discover research relevant for your work.